Atomically thin membranes to transform chemical separations. Energy-efficient chemical separation is at the heart of modern resource and manufacturing industries, central to a prosperous and sustainable Australia. This project aims to develop next generation membrane technologies to transform chemical separations by employing recent breakthrough in materials discovery and nanofluidics. Expected outcomes include new fundamental understandings on sub-continuum transport physics and new atomically ....Atomically thin membranes to transform chemical separations. Energy-efficient chemical separation is at the heart of modern resource and manufacturing industries, central to a prosperous and sustainable Australia. This project aims to develop next generation membrane technologies to transform chemical separations by employing recent breakthrough in materials discovery and nanofluidics. Expected outcomes include new fundamental understandings on sub-continuum transport physics and new atomically thin membranes that enable energy-efficient separations for processing challenging streams beyond water purification. This project aims to position Australia at the forefront of sustainable separation technology and make the local resource and manufacturing industries more sustainable and globally competitive.Read moreRead less
Centre For Clinical Research Excellence In Respiratory And Sleep Medicine
Funder
National Health and Medical Research Council
Funding Amount
$2,200,000.00
Summary
The CCRE will enhance Australia's international research reputation in clinical respiratory and sleep medicine by enhancing links between hospital-based investigators. This will foster development of new clinical researchers in these fields. Major research projects will include reducing side effects of asthma therapy in the elderly, better and cheaper ways of diagnosing disorders such as sleep apnoea and blood clots in the lung, keeping patients with chronic lung diseases out of hospital and avo ....The CCRE will enhance Australia's international research reputation in clinical respiratory and sleep medicine by enhancing links between hospital-based investigators. This will foster development of new clinical researchers in these fields. Major research projects will include reducing side effects of asthma therapy in the elderly, better and cheaper ways of diagnosing disorders such as sleep apnoea and blood clots in the lung, keeping patients with chronic lung diseases out of hospital and avoiding accidents due to lack of sleep.Read moreRead less
In situ microbial conversion of coal to methane: Biotechnology development for clean use of Australian coal. We will develop a biotechnology that uses native microorganisms to accelerate the underground conversion of coal to methane. Approximately 90% of Australia’s coal resources cannot be accessed economically using traditional mining technologies. A technology that converts coal to methane could generate an energy supply worth an estimated $60 billion, foster the development of an energy indu ....In situ microbial conversion of coal to methane: Biotechnology development for clean use of Australian coal. We will develop a biotechnology that uses native microorganisms to accelerate the underground conversion of coal to methane. Approximately 90% of Australia’s coal resources cannot be accessed economically using traditional mining technologies. A technology that converts coal to methane could generate an energy supply worth an estimated $60 billion, foster the development of an energy industry now in its infancy, and generate numerous new employment opportunities. Environmentally, methane is a cleaner burning fuel than coal, uses much less water for processing and generates the same quantity of electricity with lower CO2 emissions. This project highlights the fact that Australia’s microbial diversity is a resource we cannot afford to ignore.Read moreRead less
We will conduct a survey of respiratory symptoms, lung function, smoking status, occupational exposures, and other risk factors among 3200 people aged 40 years and over living in five Australian communities: Melbourne, Sydney, Tasmania, Busselton (WA), and the Kimberley region (WA). In the Kimberley we will survey 400 Aboriginal people and 400 non-Aboriginal people. We will use a survey methodology that has been developed by an international expert panel and has been implemented in many other co ....We will conduct a survey of respiratory symptoms, lung function, smoking status, occupational exposures, and other risk factors among 3200 people aged 40 years and over living in five Australian communities: Melbourne, Sydney, Tasmania, Busselton (WA), and the Kimberley region (WA). In the Kimberley we will survey 400 Aboriginal people and 400 non-Aboriginal people. We will use a survey methodology that has been developed by an international expert panel and has been implemented in many other countries (in North and South America, Asia, and Europe). This study will provide the first nationally-representative information on the burden of chronic obstructive pulmonary disease (COPD) and the opportunities for health gain by improving the management of this illness. In Australia, COPD is a relatively silent and under-recognised disease but nevertheless is the third most important contributor to the burden of disease and the third leading cause of hospital admission as well as being the underlying cause of 4.2% of all deaths. The information we will collect is needed to form a basis for prevention and disease management interventions to reduce the burden of COPD, particularly among population sub-groups who are disproportionately affected, either due to greater exposure to risk factors (mainly tobacco smoking and occupation), greater susceptibility, under-recognition and under-diagnosis, or inadequate disease management. Importantly, the study will serve to raise awareness about the hazards of smoking for all Australians. By identifying target groups, prevalent exposures and management deficiencies, it will lead the way towards policy-relevant randomised controlled trials testing community-based interventions to prevent COPD and-or manage it more effectively. The information collected will help advance knowledge of the prevalence, burden and treatment of COPD that will be relevant to communities throughout the world.Read moreRead less
The Clinical Utility Of Small Airway Function Tests In Paediatric Respiratory Disease
Funder
National Health and Medical Research Council
Funding Amount
$64,631.00
Summary
Respiratory disease is an important child health issue with long term implications into adulthood. The evaluation of small airways involvement in disease processes, using an accurate sensitive measures of function, such as forced oscillation technique and multiple breath washout, potentially facilitates not only early detection of disease, but instigation of earlier treatment, better assessment of response to treatment, and ultimately better outcome.
Enabling low greenhouse gas emissions from road vehicles through the proper use of alternative fuels. A major increase in alternative transport fuel use appears necessary in our response to the challenges of climate change and energy security. This proposal will advance our fundamental understanding of key aspects of the combustion of particular alternative fuels, thus enabling proper engine design and so maximising greenhouse and energy security benefits. Further, the Australian automotive indu ....Enabling low greenhouse gas emissions from road vehicles through the proper use of alternative fuels. A major increase in alternative transport fuel use appears necessary in our response to the challenges of climate change and energy security. This proposal will advance our fundamental understanding of key aspects of the combustion of particular alternative fuels, thus enabling proper engine design and so maximising greenhouse and energy security benefits. Further, the Australian automotive industry is a major employer and exporter, and needs to develop and/or maintain international leadership in low emission technologies to ensure its long term viability. This proposal builds a consortium of local organisations with common interests, thus helping local industry respond to several, significant challenges that they presently face.Read moreRead less
Implementing Evidence Into Practice To Improve Chronic Lung Disease Management In Indigenous Australians: The Breathe Easy, Walk Easy-Lungs For Life (BE WELL) Project
Funder
National Health and Medical Research Council
Funding Amount
$780,089.00
Summary
The burden of chronic obstructive pulmonary disease (COPD) in Indigenous Australians far exceeds that in non-Indigenous Australians. The project will evaluate whether the BE WELL program can build the capacity of Aboriginal health workers to provide affordable and effective management of COPD, including pulmonary rehabilitation. This program will improve health outcomes, reduce hospital admissions and address the poor access to best-practice management of COPD in Indigenous communities.
Breathe Well: Improving Cancer Imaging And Targeted Radiotherapy Using Audiovisual Biofeedback
Funder
National Health and Medical Research Council
Funding Amount
$606,847.00
Summary
Irregular breathing causes anatomical errors in medical images and consequently cancer targeting accuracy, resulting in poorer clinical outcomes and increased health care costs. We have developed and patented the Breathe Well Audio Visual (AV) biofeedback device, to improve breathing regularity. Our goal is to gather critical scientific information and reach commercial proof-of-concept objectives that will allow us to attract investment to establish a viable medical device enterprise.
The Use Of Gene-Silencing Nanodrugs To Inhibit Lung Cancer Growth
Funder
National Health and Medical Research Council
Funding Amount
$452,950.00
Summary
Lung cancer accounts for the most cancer deaths worldwide. This research proposal will use state-of-the-art nanomedicines designed to penetrate lung tumours and suppress a gene which drives cancer growth and resistance to chemotherapy drugs. Our results could underpin new approaches that revolutionise more effective and less toxic treatments for a highly lethal malignancy.
A Randomised Controlled Trial Of Interventional Versus Conservative Treatment Of Primary Spontaneous Pneumothorax
Funder
National Health and Medical Research Council
Funding Amount
$412,315.00
Summary
Primary spontaneous pneumothorax (PSP) is a collapsed lung that occurs in otherwise healthy people without underlying lung disease. Current standard treatment is to insert a chest drain into the chest to remove the air around the collapsed lung so that the lung re-inflates rapidly ("interventional treatment"). We will determine whether doing nothing, i.e. letting the lung re-inflate slowly on its own over several weeks ("conservative treatment"), is just as good or even better for patients.